124 related articles for article (PubMed ID: 16462026)
1. Interaction of intestinal nucleoside transporter hCNT2 with amino acid ester prodrugs of floxuridine and 2-bromo-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
Shin HC; Kim JS; Vig BS; Song X; Drach JC; Amidon GL
Biol Pharm Bull; 2006 Feb; 29(2):247-52. PubMed ID: 16462026
[TBL] [Abstract][Full Text] [Related]
2. Functional expression and characterization of a sodium-dependent nucleoside transporter hCNT2 cloned from human duodenum.
Shin HC; Landowski CP; Sun D; Vig BS; Kim I; Mittal S; Lane M; Rosania G; Drach JC; Amidon GL
Biochem Biophys Res Commun; 2003 Aug; 307(3):696-703. PubMed ID: 12893280
[TBL] [Abstract][Full Text] [Related]
3. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
[TBL] [Abstract][Full Text] [Related]
4. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis.
Vig BS; Lorenzi PJ; Mittal S; Landowski CP; Shin HC; Mosberg HI; Hilfinger JM; Amidon GL
Pharm Res; 2003 Sep; 20(9):1381-8. PubMed ID: 14567631
[TBL] [Abstract][Full Text] [Related]
5. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
6. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
7. Bifunctional and Unusual Amino Acid β- or γ-Ester Prodrugs of Nucleoside Analogues for Improved Affinity to ATB
Sun Y; Ke Y; Li C; Wang J; Tu L; Hu L; Jin Y; Chen H; Gong J; Yu Z
J Med Chem; 2020 Oct; 63(19):10816-10828. PubMed ID: 32882127
[TBL] [Abstract][Full Text] [Related]
8. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
Landowski CP; Lorenzi PL; Song X; Amidon GL
J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
[TBL] [Abstract][Full Text] [Related]
9. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
10. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
11. Floxuridine amino acid ester prodrugs: enhancing Caco-2 permeability and resistance to glycosidic bond metabolism.
Landowski CP; Song X; Lorenzi PL; Hilfinger JM; Amidon GL
Pharm Res; 2005 Sep; 22(9):1510-8. PubMed ID: 16132363
[TBL] [Abstract][Full Text] [Related]
12. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y; Hilfinger JM; Amidon GL
Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
[TBL] [Abstract][Full Text] [Related]
14. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
15. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Lang TT; Young JD; Cass CE
Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
[TBL] [Abstract][Full Text] [Related]
16. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
Landowski CP; Vig BS; Song X; Amidon GL
Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
[TBL] [Abstract][Full Text] [Related]
18. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line.
Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T
J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069
[TBL] [Abstract][Full Text] [Related]
19. Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters.
Tsume Y; Vig BS; Sun J; Landowski CP; Hilfinger JM; Ramachandran C; Amidon GL
Molecules; 2008 Jun; 13(7):1441-54. PubMed ID: 18719516
[TBL] [Abstract][Full Text] [Related]
20. Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.
Anand BS; Patel J; Mitra AK
J Pharmacol Exp Ther; 2003 Feb; 304(2):781-91. PubMed ID: 12538834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]